NAMPT overexpression has been observed in multiple malignant tumors, including breast, ovarian, thyroid, gastric, prostate and colorectal cancers, gliomas, and malignant lymphomas (Tan et al., 2015). This evidence concerns the gene NAMPT and central nervous system cancer.